What was Thermo Fisher Scientific's core business during this period?

Based on the company's historical evolution, during the period ending in 1995, Thermo Fisher Scientific was likely focused on providing analytical instruments, reagents, consumables, and software for scientific research, healthcare, and industrial applications. Its business revolved around enabling scientific discovery and improving diagnostics.

What financial performance information is available from this 1996 filing?

This particular snippet from the 10-K filing primarily consists of directory listings for the archived document. It does not contain detailed financial statements (like revenue, net income, or balance sheet figures) or management's discussion and analysis. To find financial performance, one would need to access the full '...-96-000026.txt' or related files within the archive.

What are the key strategic priorities for Thermo Fisher Scientific in 1995-1996?

Without access to the full report's narrative sections, specific strategic priorities for 1995-1996 are not detailed here. However, given the company's later trajectory, it was likely focused on organic growth within its existing product lines, potential market expansion, and possibly early-stage evaluation of strategic acquisitions to build scale and technological capabilities in the scientific sector.

How significant were acquisitions for Thermo Fisher around 1995?

While the limited information here doesn't specify, the mid-1990s represented a foundational period for Thermo Fisher Scientific. Although the company would later become known for its aggressive acquisition strategy, in 1995, it was likely more focused on integrating its existing businesses and establishing a stronger market presence, with acquisitions potentially being considered as part of a longer-term growth plan.

TMO 10-K FY1995 Annual Report — Revenue, Net Income, EPS

Summary

Thermo Fisher Scientific Inc.'s (TMO) 10-K filing for the period ending December 29, 1995, provides a snapshot of the company's financial and operational status as it entered a period of significant growth and integration. While this filing is historical and lacks the detailed financial statements and management discussions typically found in later filings, it indicates the company's foundational stage. Investors at this time would have been focused on the company's core business segments, potential for expansion, and overall market position within the scientific instrumentation and services sector. The company's focus on providing analytical instruments, reagents, and consumables positioned it to benefit from ongoing advancements in scientific research and diagnostics. The limited information available from this specific filing suggests that Thermo Fisher was likely in the process of building its scale and market presence, making its strategic direction and any nascent M&A activity key areas of interest for potential investors looking for growth opportunities.

Key Highlights

1The filing pertains to Thermo Fisher Scientific Inc. (TMO) for the fiscal year ending December 29, 1995, filed on March 13, 1996.
2This is a historical 10-K filing, indicating the company was publicly traded and subject to SEC reporting requirements in the mid-1990s.
3The filing is part of the SEC's EDGAR database, which provides access to public company filings.
4Information within this specific filing snippet is limited to directory listings, suggesting it precedes the detailed financial and narrative sections of a typical 10-K.
5The period covered (fiscal year 1995) places the company in a pre-major acquisition era, before its significant growth through mergers and acquisitions.
6Investors in 1996 would have been evaluating Thermo Fisher based on its then-current market position and future growth prospects in the scientific instrumentation and services sector.

THERMO FISHER SCIENTIFIC INC. Annual Report, Year Ended Dec 30, 1995

Summary

Key Highlights

Frequently Asked Questions